Chugai Pharma
Chugai Pharma
Community score
+2.28
Industry: Biotechnology & Pharmaceuticals
Listing country:
Japan
Year added:
2018
Founded in 1925 and headquartered in Tokyo, Japan, the company is prominently involved in the pharmaceutical industry with a focus on five key business segments: Oncology, Renal diseases, Bone and joint diseases, Hematology, and Neurology. It boasts a portfolio of notable brands that include Activase (alteplase), Kadcyla (ado-trastuzumab emtansine), Perjeta (pertuzumab), Alecensa (alectinib), and Hemlibra (emicizumab). While its products are sold globally, the company has a particularly strong presence in its home country of Japan. The company's international distribution and sales are bolstered through its affiliation with the Roche Group, which possesses a broad international network. (Powered by AI)
Show Company Information
You view a limited profile page without scores and metrics
availability. Subscribing users get to see more advanced data, want to
see it in action? Click on a company you are interested in:
.
Ghulam G. January 12th, 2024
Manisha
R. January 3rd, 2024
Abdulmajeed V. January 3rd, 2024
Gift O. October 21st, 2023
Muhammad Aqib A. February 20th, 2024
Dolapo J. August 26th, 2023 Gift O. June 6th, 2023 Gift O. October 4th, 2023